• Kurdadze E. ქურდაძე ე.
  • Lobjanidze N. ლობჟანიძე ნ.
  • Kobidze T. კობიძე თ.
  • Chavchanidze N. ჭავჭანიძე ნ.
  • Topuria D. თოფურია დ.



Acute intoxication with colchicine is quite rare pathology  and it is not described in Georgia until now. Despite rare clinical cases intoxication with colchicine deserves attention in order to avoid its severe complications. The most severe complication characteristic for colchicine intoxication is polyorganic insufficiency which frequently has fatal outcome. We represent the case from our practice. 17 years old girl on the background of nervous stress in purpose of suicide took 32 (1 mg) tablets of colchicine in total 0.7 mg/ kg of body weight (lethal dose is >0.8 mg/kg). Intoxication was expressed by acute respiratory insufficiency, hemoperitoneum, with disseminated intravascular coagulation, sepsis, swelling of brain. Parallel to symptomatic-detoxication treatment  60 doses of fresh frozen plazma (FFP) was  used, 24 doses of thrombomass, as well as human granulocyte colony-stimulating factor (G-CSF) – Tevagrastim. It has to be noted that on IV day of intoxication based on corresponding study hemoperitoneum diagnosis  was determined, surgical intervention was conducted.  By US existence of fluid in both pleural cavities was determined. Punctate of hemorrhagic genesis was received by centesis. Assisted ventilation was conducted in post-surgical period. On XII day extubation was done. Active hairloss  started on VII-VIII day finished with alopecia on XVI day. After intensive treatment despite existed severe complications  the patient was placed on outpatient treatment from XX day with stabile hemodynamics.  The case is interesting as rare case, it is distinguished with multiplicity and, what is important, it shows tha in case of timely conducted adequate treatment, the process is reversible and finishes with complete recovery.  Before implementation of antitoxic serum (Colchicine specific antibodies) in clinical practice fresh frozen plazma (FFP)  infusion can be considered as optimal mean for poison excretion, because the poison after absorption joins exactly 50% of plasma protein.  In our opinion positive outcome of patient is conditioned  by adequate and  timely intervention which represents  precondition for effective treatment of intoxicated patients.


Download data is not yet available.


Metrics Loading ...


1. Schier JG. Colchicine, podophillyn, and the vinca alkaloids. In: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE, eds. Goldfrank‘s toxicologic emergencies. New York: McGraw-Hill 2011; 537-48.
2. Achtert G, Scherrmann JM, Christen MO. Pharmaco- kinetics/bioavailability of colchicine in healthy male volun- 127 128 teers. Eur J Drug MetabPharmacokinet. 1989;14:317-322.
3. Alayli G, Cengiz K, Canturk F, et al. Acute myopathy in a patient with concomitant use of pravastatin and colchicine. Ann Pharmacother. 2005;39:1358-61.
4. Finkelstein Y, Aks SE, Hutson JR, et al. Colchicine poisoning: the dark side of an ancient drug. ClinToxicol 2010;48:407 -14.
5. Nuki G, Colchiin: its mechanism of action and efficacy in crystalinducedinflammation. CurrRheumatol Rep 2008;10:218-27.
6. Achtert G, Scherrmann JM, Christen MO. Pharmacokinetics/biovailability of colchicine in healthy male volunteers. Eur J Drug Metabfarmacokinet. 1989;14:317-322




How to Cite

ქურდაძე ე. K. E., ლობჟანიძე ნ. L. N., კობიძე თ. K. T., ჭავჭანიძე ნ. C. N., & თოფურია დ. T. D. (2019). ACUTE COLCHICINE POISONING IN GEORGIA TSSU, CLINICAL TOXICOLOGY. TSMU COLLECTION OF SCIENTIFIC WORKS, 49, 125–128.